|
Permission to use, copy and distribute documents presented on this World Wide Web site and related graphics is not granted without prior written permission of Technology Networks Ltd
To obtain this permission contact:
Technology Networks Ltd
Unit 6, Woodview
Bull Lane
Acton
Sudbury
CO10 0FD, U.K.
In cases where permission is granted, it is done so under the provision that the above copyright notice and this permission notice appear in all copies. All other rights are reserved.
The information and data included in the TechnologyNetworks.com WWW site, and all its affiliated websites and associated email newsletters, have been compiled from a variety of sources, and are subject to change without notice. Technology Networks Ltd. makes no warranties or representations whatsoever regarding the quality, content, completeness, or adequacy of this information and data.
Technology Networks Ltd. specifically disclaims all warranties with respect to this WWW site, email newsletters or your use thereof, express, implied, or otherwise, including without limitation, all warranties of merchantability and fitness for a particular purpose. Technology Networks Ltd shall not be liable for any special, incidental, or consequential damages, including, without limitation, lost revenues, lost profits, or loss of prospective economic advantage, resulting from the use or misuse of this site, or the information therein.
|
Study of Helicobacter pylori Genotype Status in Saliva, Dental Plaques, Stool and Gastric Biopsy SamplesThis study aimed to compare H. pylori cagA and the vacA allelic status among strains isolated from saliva, dental plaque, gastric biopsies and stool samples in the same patient with dyspepsia manifestations in order to evaluate the mode of transmission of H. pylori infection. Serious Bacterial Infection Biomarkers Uncovered using Transcriptomic AnalysisNovel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children. Genetic Predictor of Breast Cancer Response to ChemotherapyGene expression 'signatures' to measure the susceptibility of tumor cells to chemotherapy. New Biomarkers Could Offer Vital Clues for Cancer ResearchEuropean funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore. National Data Center for Cancer Genome ResearchIn the wake of personalized medicine, scientists at the University of California, Santa Cruz, make progress in the management and analysis of large data sets. Using the Sequenced Genome to Tackle DiseaseUMass Amherst geneticist develops tool to identify genes important in disease and for tailoring individual treatment. Selection of Suitable Reference Genes for RT-qPCR Analyses in CyanobacteriaIn this work we have validated candidate reference genes for accurate normalization of RT-qPCR data in cyanobacteria. Several genes were selected and their transcription analyzed in three morphological distinct organisms. DNA Methylation Analysis of Bone Marrow Cells at Diagnosis of Acute Lymphoblastic Leukemia and at RemissionThe aim of this study was to identify genes that display aberrant DNA methylation independently of cytogenetic ALL subtype for further mechanistic studies of ALL. Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian CarcinomaThe Cancer Genome Atlas (TCGA) Network recently catalogued the molecular aberrations in 487 high-grade serous ovarian cancers. This study surveys the miRNAs, in the context of their predicted gene targets. Enzo Biochem Launches Test for Measuring Risk of Colorectal CancerCompany developing pipeline of new platforms and assays for molecular diagnostic use.
|